新闻中心

News Center

Our company participated in the 15th Chinese Medical Doctor Association Psychiatry Annual Meeting and held a special meeting

Release Time

2022-06-22 09:35

      Improve the quality, improve the image, and be a respected psychiatrist. With the theme of "civilization and sunshine", the 15th annual meeting of the psychiatrist branch of the Chinese Medical Doctor Association (CPA 2019) was held in Xi'an on April 12. More than 3,500 domestic and foreign psychiatrists gathered together to discuss the development of mental health in China. Sponsored by the editorial board of "New Perspectives in Psychiatry" and undertaken by Shenzhen Pangu Pharmaceutical Co., Ltd., the "New Perspectives in Psychiatry" symposium was successfully held on April 12 in Conference Room 208-210 of Qujiang International Conference Center. Three professors, Wang Gaohua, Hao Wei, and Fang Yiru, were invited to chair the meeting, and three professors, Si Tianmei, Wang Huiling, and Li Yi, were the speakers. The symposium is divided into three parts: "Rehabilitation and Treatment of Patients with Schizophrenia", "Sleep Management of Patients with Schizophrenia" and "The 'Chain' of Essence", which attracted more than 200 physicians to attend.

 

 

Prof. Wang Gaohua, Prof. Hao Wei and Prof. Fang Yiru presided over the meeting.

 

       

      Professor Si Tianmei, deputy director of the Psychiatry Branch of the Chinese Medical Association and editorial board member of the Chinese version of COP, gave a special speech on "Rehabilitation and Treatment of Patients with Schizophrenia", pointing out that the purpose of treatment for schizophrenia is rehabilitation, and a single dose of antipsychotic drugs for patients with schizophrenia After treatment, the probability of relapse is very high, and patients with schizophrenia should adhere to long-term treatment.

 

 

       Professor Wang Huiling, member of the Psychiatry Branch of the Chinese Medical Association and associate editor of the Chinese version of COP, gave a keynote speech on "Sleep in Patients with Schizophrenia", pointing out that 80% of patients with schizophrenia have sleep and circadian rhythm disorders, and sleep should be paid attention to during the treatment of patients with schizophrenia improve.

 

 

       Professor Li Yi, member of the Psychiatry Branch of the Chinese Medical Association and editorial board member of the Chinese version of COP, gave a keynote speech on the "chain of essence", sharing the "impression" of schizophrenia, the "chain" of etiology and the "practice" of learning and understanding 3 This special topic vividly introduces the latest research progress in the field of schizophrenia.

 

 

       At the end of the meeting, Prof. Hao Wei concluded that the goal of schizophrenia treatment is rehabilitation, and emphasis is placed on sleep management. At the same time, schizophrenia faces many challenges that need to be solved by all psychiatrists.

Related News

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

2022-05-25

图片名称

2021-Foncoo Public Welfare

On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.

2022-05-25

图片名称

Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Official announcement! Seriously, don't be distracted!

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.

2022-05-25

图片名称

"Bupropion Hydrochloride Sustained-Release Tablets (II)" exclusively sold by Foncoo Pharmaceuticals was approved in China

Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".

2022-05-25

图片名称